SIGLEC1 and neoplasm: Consistent with this, in Cox multivariate analysis after adjusting for clinical parameters such as ER, PR, Her2, grade, and tumor size, SIGLEC1 high expression was independently significantly associated with shorter DSS (HR = 1.42, p = 1.85 × 10−0.4, Table S4).